Bone Biologics Corp (BBLG) income statement
BBLGNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 26, 2026Score 6/30
$0.29−0.02 (-5.92%)
Close on Nov 18, 2026Market cap $986.22KP/E –Yield –
Bone Biologics Corp income statement
Ratios
Latest available, balances at Sep 30, 2026
Profitability, FY
- Gross margin
- –
- Operating margin
- –
- Net margin
- –
- Return on equity, FY2025
- -70.2%
Financial strength
- Current ratio
- 13.38
- Debt to equity
- –
- Debt to assets
- –
- Cash to current liabilities
- 1266.3%
Valuation
- P/E ratio
- –
- Price to sales
- –
- Price to book
- 0.17
- Dividend yield
- –
See a number that looks wrong?